Literature DB >> 17440443

Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.

Brian C Beard1, David Dickerson, Kate Beebe, Christina Gooch, James Fletcher, Tulin Okbinoglu, Daniel G Miller, Michael A Jacobs, Rajinder Kaul, Hans-Peter Kiem, Grant D Trobridge.   

Abstract

The potential for leukemia caused by retroviral vector integration has become a significant concern for hematopoietic stem cell gene therapy. We analyzed the distribution of vector integrants in pigtailed macaque and baboon repopulating cells for the two most commonly used retroviral vector systems, human immunodeficiency virus (HIV)-based lentiviral vectors and murine leukemia virus (MLV)-based gammaretroviral vectors, to help define their relative genotoxicity. All animals had polyclonal engraftment with no apparent adverse effects from transplantation with gene-modified cells. In all, 380 MLV and 235 HIV unique vector integration sites were analyzed and had distinct distribution patterns in relation to genes and CpG islands as observed in previous in vitro studies. Both vector types were found more frequently in and near proto-oncogenes in repopulating cells than in a random dataset. Analysis of functional classes of genes with integrants within 100 kilobases (kb) of their transcription start sites showed an over-representation of genes involved in growth or survival near both lentiviral and gammaretroviral integrants. Microarray analysis showed that both gammaretroviral and lentiviral vectors were found close to genes with high expression levels in primitive cells enriched for hematopoietic stem cells. These data help define the relative risk of insertional mutagenesis with MLV-, HIV-, and simian immunodeficiency virus (SIV)-based vectors in a highly relevant primate model.

Entities:  

Mesh:

Year:  2007        PMID: 17440443     DOI: 10.1038/sj.mt.6300159

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  54 in total

Review 1.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

2.  Dotting the I's and crossing the T's: integration analyses in transduced patient T cells.

Authors:  John J Rossi
Journal:  Mol Ther       Date:  2009-05       Impact factor: 11.454

3.  Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.

Authors:  Patrick M Younan; Christopher W Peterson; Patricia Polacino; John P Kowalski; Willimark Obenza; Hannah W Miller; Brian P Milless; Phil Gafken; Stephen C DeRosa; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2015-02-04       Impact factor: 11.454

4.  Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.

Authors:  Olga S Kustikova; Bernhard Schiedlmeier; Martijn H Brugman; Maike Stahlhut; Stefan Bartels; Zhixiong Li; Christopher Baum
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

5.  Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors.

Authors:  Grant D Trobridge; Brian C Beard; Christina Gooch; Martin Wohlfahrt; Philip Olsen; James Fletcher; Punam Malik; Hans-Peter Kiem
Journal:  Blood       Date:  2008-04-03       Impact factor: 22.113

6.  Genome-wide mapping of PiggyBac transposon integrations in primary human T cells.

Authors:  Daniel L Galvan; Yozo Nakazawa; Aparna Kaja; Claudia Kettlun; Laurence J N Cooper; Cliona M Rooney; Matthew H Wilson
Journal:  J Immunother       Date:  2009-10       Impact factor: 4.456

7.  Long-term regulation of genetically modified primary hematopoietic cells in dogs.

Authors:  Kiyoshi Okazuka; Brian C Beard; David W Emery; Kerstin Schwarzwaelder; Michele R Spector; George E Sale; Christof von Kalle; Beverly Torok-Storb; Hans-Peter Kiem; C Anthony Blau
Journal:  Mol Ther       Date:  2011-02-15       Impact factor: 11.454

Review 8.  Genotoxicity of retroviral hematopoietic stem cell gene therapy.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2011-03-07       Impact factor: 4.388

Review 9.  Retroviral vector interactions with hematopoietic cells.

Authors:  Elizabeth M Everson; Grant D Trobridge
Journal:  Curr Opin Virol       Date:  2016-08-10       Impact factor: 7.090

10.  Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors.

Authors:  Joerg Enssle; Grant D Trobridge; Kirsten A Keyser; Christina Ironside; Brian C Beard; Hans-Peter Kiem
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.